Percutaneous transluminal angioplasty

The procedure of choice in the hypertensive renal allograft recipient with renal artery stenosis

Stuart M. Greenstein, A. Verstandig, G. K. McLean, D. C. Dafoe, D. R. Burke, S. G. Meranze, A. Naji, R. A. Grossman, L. J. Perloff, C. F. Barker

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

A retrospective review of 547 renal transplants performed over a six-year period revealed allograft renovascular hypertension secondary to RTAS in 39 (7.1%) patients. Percutaneous transluminal angioplasty (PTA) resulted in immediate cure or improvement in 76% of the patients, increasing to 83% in patients with functioning kidneys at a mean follow-up period of 30 months (1-72 months). The renal artery stenosis (RTAS) was equally distributed between living-related and cadaver kidney recipients and did not appear to be more prevalent in end-to-end or end-to-side anastomoses. The blood pressures fell from pre-PTA levels of 167 ± 22 mmHg systolic to 141 ± 23.7 post-PTA and 102 ± 11 mmHg diastolic pre-PTA to 88 ± 12 mmHg post-PTA (P<0.01). Of 25 cured or improved patients, 24 are on significantly less hypertensive medication. Two patients died of causes unrelated to the PTA and only one patient lost a kidney because of the procedure. Compared with operation, PTA is a safer and more effective procedure for the initial treatment of RTAS.

Original languageEnglish (US)
Pages (from-to)29-32
Number of pages4
JournalTransplantation
Volume43
Issue number1
StatePublished - 1987
Externally publishedYes

Fingerprint

Renal Artery Obstruction
Angioplasty
Allografts
Kidney
Renovascular Hypertension
Cadaver
Blood Pressure
Transplants

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Greenstein, S. M., Verstandig, A., McLean, G. K., Dafoe, D. C., Burke, D. R., Meranze, S. G., ... Barker, C. F. (1987). Percutaneous transluminal angioplasty: The procedure of choice in the hypertensive renal allograft recipient with renal artery stenosis. Transplantation, 43(1), 29-32.

Percutaneous transluminal angioplasty : The procedure of choice in the hypertensive renal allograft recipient with renal artery stenosis. / Greenstein, Stuart M.; Verstandig, A.; McLean, G. K.; Dafoe, D. C.; Burke, D. R.; Meranze, S. G.; Naji, A.; Grossman, R. A.; Perloff, L. J.; Barker, C. F.

In: Transplantation, Vol. 43, No. 1, 1987, p. 29-32.

Research output: Contribution to journalArticle

Greenstein, SM, Verstandig, A, McLean, GK, Dafoe, DC, Burke, DR, Meranze, SG, Naji, A, Grossman, RA, Perloff, LJ & Barker, CF 1987, 'Percutaneous transluminal angioplasty: The procedure of choice in the hypertensive renal allograft recipient with renal artery stenosis', Transplantation, vol. 43, no. 1, pp. 29-32.
Greenstein, Stuart M. ; Verstandig, A. ; McLean, G. K. ; Dafoe, D. C. ; Burke, D. R. ; Meranze, S. G. ; Naji, A. ; Grossman, R. A. ; Perloff, L. J. ; Barker, C. F. / Percutaneous transluminal angioplasty : The procedure of choice in the hypertensive renal allograft recipient with renal artery stenosis. In: Transplantation. 1987 ; Vol. 43, No. 1. pp. 29-32.
@article{e01e682d3cd14b5dbf0829f36a4c3f45,
title = "Percutaneous transluminal angioplasty: The procedure of choice in the hypertensive renal allograft recipient with renal artery stenosis",
abstract = "A retrospective review of 547 renal transplants performed over a six-year period revealed allograft renovascular hypertension secondary to RTAS in 39 (7.1{\%}) patients. Percutaneous transluminal angioplasty (PTA) resulted in immediate cure or improvement in 76{\%} of the patients, increasing to 83{\%} in patients with functioning kidneys at a mean follow-up period of 30 months (1-72 months). The renal artery stenosis (RTAS) was equally distributed between living-related and cadaver kidney recipients and did not appear to be more prevalent in end-to-end or end-to-side anastomoses. The blood pressures fell from pre-PTA levels of 167 ± 22 mmHg systolic to 141 ± 23.7 post-PTA and 102 ± 11 mmHg diastolic pre-PTA to 88 ± 12 mmHg post-PTA (P<0.01). Of 25 cured or improved patients, 24 are on significantly less hypertensive medication. Two patients died of causes unrelated to the PTA and only one patient lost a kidney because of the procedure. Compared with operation, PTA is a safer and more effective procedure for the initial treatment of RTAS.",
author = "Greenstein, {Stuart M.} and A. Verstandig and McLean, {G. K.} and Dafoe, {D. C.} and Burke, {D. R.} and Meranze, {S. G.} and A. Naji and Grossman, {R. A.} and Perloff, {L. J.} and Barker, {C. F.}",
year = "1987",
language = "English (US)",
volume = "43",
pages = "29--32",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Percutaneous transluminal angioplasty

T2 - The procedure of choice in the hypertensive renal allograft recipient with renal artery stenosis

AU - Greenstein, Stuart M.

AU - Verstandig, A.

AU - McLean, G. K.

AU - Dafoe, D. C.

AU - Burke, D. R.

AU - Meranze, S. G.

AU - Naji, A.

AU - Grossman, R. A.

AU - Perloff, L. J.

AU - Barker, C. F.

PY - 1987

Y1 - 1987

N2 - A retrospective review of 547 renal transplants performed over a six-year period revealed allograft renovascular hypertension secondary to RTAS in 39 (7.1%) patients. Percutaneous transluminal angioplasty (PTA) resulted in immediate cure or improvement in 76% of the patients, increasing to 83% in patients with functioning kidneys at a mean follow-up period of 30 months (1-72 months). The renal artery stenosis (RTAS) was equally distributed between living-related and cadaver kidney recipients and did not appear to be more prevalent in end-to-end or end-to-side anastomoses. The blood pressures fell from pre-PTA levels of 167 ± 22 mmHg systolic to 141 ± 23.7 post-PTA and 102 ± 11 mmHg diastolic pre-PTA to 88 ± 12 mmHg post-PTA (P<0.01). Of 25 cured or improved patients, 24 are on significantly less hypertensive medication. Two patients died of causes unrelated to the PTA and only one patient lost a kidney because of the procedure. Compared with operation, PTA is a safer and more effective procedure for the initial treatment of RTAS.

AB - A retrospective review of 547 renal transplants performed over a six-year period revealed allograft renovascular hypertension secondary to RTAS in 39 (7.1%) patients. Percutaneous transluminal angioplasty (PTA) resulted in immediate cure or improvement in 76% of the patients, increasing to 83% in patients with functioning kidneys at a mean follow-up period of 30 months (1-72 months). The renal artery stenosis (RTAS) was equally distributed between living-related and cadaver kidney recipients and did not appear to be more prevalent in end-to-end or end-to-side anastomoses. The blood pressures fell from pre-PTA levels of 167 ± 22 mmHg systolic to 141 ± 23.7 post-PTA and 102 ± 11 mmHg diastolic pre-PTA to 88 ± 12 mmHg post-PTA (P<0.01). Of 25 cured or improved patients, 24 are on significantly less hypertensive medication. Two patients died of causes unrelated to the PTA and only one patient lost a kidney because of the procedure. Compared with operation, PTA is a safer and more effective procedure for the initial treatment of RTAS.

UR - http://www.scopus.com/inward/record.url?scp=0023129612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023129612&partnerID=8YFLogxK

M3 - Article

VL - 43

SP - 29

EP - 32

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 1

ER -